| My Account | Subscribe | Contact Us | Donate |
Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.
Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.
Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.
Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.
CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Type 1 Issues Articles
Candesartan not only reduced the occurrence of retinopathy in patients who entered the study free of the condition, but also slowed the progression of the disease in those who already had it.
According to the British public health organization Diabetes UK, a four-year study has shown that the drug candesartan reduces the chances of people with type 1 diabetes developing retinopathy by almost 20 percent.
These findings could lead to the first-time use of a drug therapy to treat retinopathy. Retinopathy, a common consequence of diabetes in which blood vessels in the eye begin to leak and then scar from the effects of high blood sugar, is currently treated with surgery or laser therapy.
Candesartan is a hypertension treatment commonly sold under the trade names Amias, Atacand, Blopress, and Ratacand by the drug companies AstraZeneca and Takeda Pharmaceuticals.
The researchers, from Imperial College in London, tracked more than 1,400 patients with type 1 diabetes, administering candesartan to 711 of them and a placebo to the remaining 710.
They noted that the drug not only reduced the occurrence of retinopathy in patients who entered the study free of the condition, but also slowed the progression of the disease in those who already had it.
Categories: Research, Type 1 Issues
Email to a Friend
Send a link to this page to your friends and colleagues.